Her3: a novel egf receptor homolog

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530/13, 195/1.23

C12N 15/54 (2006.01) C07K 14/71 (2006.01) C12N 9/12 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2037440

ABSTRACT The cloning, sequence and expression of a novel member of the EGFR/neu subfamily of receptor tyrosine kinases, termed HER3, is described. The HER3 precursor comprises 1342 amino acid residues, 1323 residues of which comprise the mature HER3. Recombinant HER3 does not interact with the homologous ligands EGF and TGF-.alpha.. A 160 kD phosphoprotein is present in cells expressing both HER3 and membrane-associated Amphiregulin, whereas the 170 kD EGF receptor is completely absent. Immunoprecipitation experiments suggest this 160 kD phosphoprotein is HER3 and that it is present only when coexpressed with the integral membrane form of the AR precursor.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Her3: a novel egf receptor homolog does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Her3: a novel egf receptor homolog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Her3: a novel egf receptor homolog will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1820640

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.